CURTI, Brendan,KOVACSOVICS-BANKOWSKI, Magdalena,WALKER, Ed,WALKER, Josh,WEINBERG, Andy
申请号：
ES12868058
公开号：
ES2740358T3
申请日:
2012.02.06
申请国别(地区):
ES
年份:
2020
代理人:
摘要：
OX40 is a potent immune stimulating target. Provided herein are methods for the treatment of cancer patients using (3X40 agonists methods to predict clinical outcome of the treatment by correlation of the treatment and an increase in OX40-induced T cell proliferation.
